MEDIPOST , Ltd. EBIT

The latest EBIT for 078160.KQ is $-81B as of June 2026. That compares with $-61B in the prior-year period — down 33.4% year over year. That is below the Healthcare sector average of $99B. Investors often review this figure alongside MEDIPOST , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 078160.KQ's EBIT moved from $-61B to $-81B — a 33.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MEDIPOST , Ltd.'s operating scale or balance-sheet position.

Against Healthcare companies, 078160.KQ currently prints $-81B for EBIT, while the sector average sits near $99B. That is roughly 181.4% below the sector mean. Large gaps often invite a closer look at MEDIPOST , Ltd.'s growth, margins, and balance sheet.

A EBIT figure of $-81B for 078160.KQ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $99B. Explore the charts below for those layers of context.

After noting 078160.KQ's EBIT ($-81B), review year-over-year change from $-61B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.